Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: A pooled analysis from the Phase 3 clinical trial programme

  1. Torres, A.
  2. Wible, M.
  3. Tawadrous, M.
  4. Irani, P.
  5. Stone, G.G.
  6. Quintana, A.
  7. Debabov, D.
  8. Burroughs, M.
  9. Bradford, P.A.
  10. Kollef, M.
Aldizkaria:
Journal of Antimicrobial Chemotherapy

ISSN: 1460-2091 0305-7453

Argitalpen urtea: 2023

Alea: 78

Zenbakia: 11

Orrialdeak: 2672-2682

Mota: Artikulua

DOI: 10.1093/JAC/DKAD280 GOOGLE SCHOLAR